Klinikai vizsgálatok Nct
Clinical Trial Results:
A multinational, multicenter, randomized, double-blind, parallel-group, placebo-controlled study, to evaluate the efficacy, tolerability and safety of two doses of laquinimod orally administered in relapsing remitting (R-R) multiple sclerosis (MS) subjects
| Summary | |
EudraCT number | 2004-003943-28 |
Trial protocol | HU IT CZ GB DE ES |
Global completion date | 28 Jun 2006 |
| Paediatric regulatory details | |
Is the trial part of an agreed EMA paediatric investigation plan? | No |
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | No |
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | No |
| Results information | |
Results version number | v1(current) |
This version publication date | 04 Jan 2017 |
First version publication date | 04 Jan 2017 |
Other versions | |
Summary report(s) | LAQ-5062 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.